TOP NEWS: AstraZeneca's Enhertu approved in EU for breast cancer form
(Alliance News) - AstraZeneca PLC on Thursday said its cancer drug Enhertu, which it develops with Daiichi Sankyo Co Ltd, has been approved in the EU for the treatment of metastatic breast cancer.
Read more